Literature DB >> 11666013

Truncated NF2 proteins are not detected in meningiomas and schwannomas.

M A Den Bakker1, A A van Tilborg, J M Kros, E C Zwarthoff.   

Abstract

Neurofibromatosis type 2 is caused by mutations in the NF2 tumor suppressor gene. The NF2 gene encodes a 595-aminoacid protein, presumably functioning as a membrane-organizing element. Theoretically, the majority of mutations found in the NF2 gene should lead to a truncated protein product. Using immunoprecipitation with an antibody raised to N-terminal sequences of the NF2 protein, the authors sought to demonstrate the presence of truncated NF2 proteins in tumors. From 17 of 19 tumors (14 meningiomas and five schwannomas), 12 of which have previously been shown to harbor truncating NF2 mutations, wild-type NF2 protein was immunoprecipitated. From two tumors no protein was precipitated. Truncated NF2 proteins were not observed. The authors conclude that mutant NF2 proteins are unstable and undergo accelerated degradation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11666013     DOI: 10.1046/j.1440-1789.2001.00394.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  3 in total

Review 1.  The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2.

Authors:  M E Baser; L Kuramoto; R Woods; H Joe; J M Friedman; A J Wallace; R T Ramsden; S Olschwang; E Bijlsma; M Kalamarides; L Papi; R Kato; J Carroll; C Lázaro; F Joncourt; D M Parry; G A Rouleau; D G R Evans
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

2.  Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.

Authors:  Caisa M Hansson; Patrick G Buckley; Giedre Grigelioniene; Arkadiusz Piotrowski; Anders R Hellström; Kiran Mantripragada; Caroline Jarbo; Tiit Mathiesen; Jan P Dumanski
Journal:  BMC Genomics       Date:  2007-01-12       Impact factor: 3.969

3.  Frequency of loss of heterozygosity of the NF2 gene in schwannomas from Croatian patients.

Authors:  Nives Pećina-Slaus; Martina Zeljko; Hrvoje Ivan Pećina; Tamara Nikuseva Martić; Niko Bacić; Davor Tomas; Reno Hrasćan
Journal:  Croat Med J       Date:  2012-08       Impact factor: 1.351

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.